A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/1997
10/22/1997	EP0801656A1 Induction of cytotoxic t-lymphocyte responses
10/22/1997	EP0801655A1 Basic proline-amide derivatives of ge 2270 and ge 2270-like antibiotics
10/22/1997	EP0801654A1 N-SUBSTITUTED GLYCINE DERIVATIVES AS INHIBITORS OF FACTOR Xa
10/22/1997	EP0801574A1 Modulation of integrin-mediated signal transduction
10/22/1997	EP0801573A1 A stabilized pharmaceutical formulation comprising a growth hormone and leu-his-leu
10/22/1997	EP0801572A2 Composition for inhibiting intimal hyperplasia using pdgf antagonists and heparin
10/22/1997	EP0801557A2 LIPOSOME FORMULATIONS OF 5$g(b) STEROIDS
10/22/1997	EP0698041B1 Synthetic aglucodalbaheptide antibiotics
10/22/1997	EP0693122A4 Glutamylcysteine synthetase light subunit
10/22/1997	EP0679093B1 Methods of delivering agents to target cells
10/22/1997	EP0576426B1 Ryegrass pollen allergen
10/22/1997	EP0485458B1 Thioacylating reagents and intermediates, thiopeptides, and methods for preparing and using same
10/22/1997	EP0228458B2 Epithelial cells expressing foreign genetic material
10/22/1997	CN1162978A Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof
10/22/1997	CN1162977A Modified Factor VII
10/22/1997	CN1162922A Rheumatoid arthritis remedy containing IL-6 antagonist as active ingredient
10/22/1997	CN1162921A A storage stable water solution for infusion containing a thrombin inhibitor
10/22/1997	CN1162920A Use of muramyl peptide compounds
10/22/1997	CN1162919A Combination preparation, containing cyclosporin a or FK506 or rapamycin and a xanthine derivative
10/22/1997	CN1162489A Nutrient liquid
10/22/1997	CN1162481A External use cream for skin pigmentation
10/21/1997	US5679809 Concentrate of polyunsaturated fatty acid ethyl esters and preparation thereof
10/21/1997	US5679797 Retroviral protease inhibiting compounds
10/21/1997	US5679783 Chordin polypeptide capable of inducing dorsal and neural tissue development in vertebrates; neurotropic growth factor
10/21/1997	US5679782 Inhibit receptor binding activity of urokinase-type plasminogen activator
10/21/1997	US5679778 For forming conjugates with macromolecules
10/21/1997	US5679777 Time-release agents comprising conjugates of genetically engineered proteins as drug carriers; enhanced stability; increased vascular retention
10/21/1997	US5679776 Contacting plasma with barium chloride, collecting supernatant, contacting supernatant with aluminum hydroxide, centrifuging, desalting, ion exchanging, collecting factor viii complex
10/21/1997	US5679774 DNA sequences of the EBV genome, recombinant DNA molecules, processes for preparing EBV-related antigens, diagnostic compositions and pharmaceutical compositions containing said antigens
10/21/1997	US5679772 Medical diagnosis, immunoassays
10/21/1997	US5679771 Administering mammalian insulin-like growth factor
10/21/1997	US5679770 Polypeptide, DNA fragment encoding the same, drug composition containing the same and process for producing the same
10/21/1997	US5679769 Synthesis of asparagine-linked glycopeptides on a polymeric solid support
10/21/1997	US5679715 Administering effective amount of (r)-(-)-n,2-dimethyl-n-2-propynylphenethylamine, commonly known as deprenyl; monoamine oxidase inhibitor
10/21/1997	US5679711 Hydroxyl ions as novel therapeutic agents and compounds that modulate these ions, compositions employing these agents, therapeutic methods for using such agents
10/21/1997	US5679687 Irreversible HIV protease inhibitors, compositions containing same and process for the preparation thereof
10/21/1997	US5679665 Pharmaceutical formulation comprised of polymyxintrimethoprim and an anti-inflammatory drug for ophthalmic and otic topical use
10/21/1997	US5679658 N,O-carbonxymethylchitosan for prevention of surgical adhesions
10/21/1997	US5679653 Diagnosis and treatment of bacterial dystentery
10/21/1997	US5679647 Methods and devices for immunizing a host against tumor-associated antigens through administration of naked polynucleotides which encode tumor-associated antigenic peptides
10/21/1997	US5679643 Glutathione analogs and paralog panels comprising glutathione mimics
10/21/1997	US5679641 Peptides of human P53 protein for use in human T cell response inducing compositions, and human P53 protein-specific cytotoxic t-lymphocytes
10/21/1997	US5679640 Immunosuppressant peptides
10/21/1997	US5679639 Serine protease derived-polypeptides and anti-peptide antibodies, systems and therapeutic methods for inhibiting coagulation
10/21/1997	US5679638 Method for treating a tumor with a chemotherapeutic agent
10/21/1997	US5679636 Bone and prostate-derived protein factors affecting prostate cancer growth, differentiation, and metastasis
10/21/1997	US5679559 Cationic polymer and lipoprotein-containing system for gene delivery
10/21/1997	US5679555 Method of using ribozyme analogs having rigid, non-nucleotidic molecular linkers
10/21/1997	US5679554 Finderons and methods of their preparation and use
10/21/1997	US5679550 Polypeptides; anticarcinogenic agents
10/21/1997	US5679546 Chimeric proteins which block complement activation
10/21/1997	US5679545 Therapy for heart failure, arrhythmic, inotropic and neurological disorders
10/21/1997	US5679542 Antithrombosis agents
10/21/1997	US5679531 Methods of detecting βA4 peptide species ending at carboxy-terminus residue 42 using monoclonal antibody 369.2B
10/21/1997	US5679530 Immunogenic complex of isolated polypeptides of specific amino acid sequence to a keyhole lampet hemocyanin
10/21/1997	US5679511 Dna sequence that encodes the protein pmel 17 and bacteriophage vector for use as a probe in the detection of the degree of melanization in a human melanocyte; prenatal diagnosis and genetic analysis of albinism
10/21/1997	US5679360 Substance P antagonist for the treatment of lichens, prurigo, pruritus
10/21/1997	US5679346 Methods of blocking adhesion with anti-lami-3 antibody
10/21/1997	US5679345 Method for preventing complement-dependent rejection of organ or tissue transplants
10/21/1997	US5679344 Includes an antiinflammatory proteolytic enzyme composition to increase to rapidity of physiological availability of glucosamine
10/21/1997	US5679339 Method of using IL-11 for treating spondyloarthropies
10/21/1997	US5679338 Use of IL-4 for inhibition of the breakdown of articular cartilage and other tissues
10/21/1997	CA2135739C Hemoglobin-enzyme complexes
10/21/1997	CA2030433C New isoquinoline- carboxamide amino acid derivatives useful for treatment of viral diseases
10/19/1997	CA2174483A1 Endogenous hypertensive system
10/17/1997	WO1996032476A1 Modulator of neuronal cell response to inhibition by cns myelin
10/17/1997	CA2217731A1 Modulator of neuronal cell response to inhibition by cns myelin
10/16/1997	WO1997038310A1 Method for detecting organ allograft rejection and uses thereof
10/16/1997	WO1997038293A2 Assays and reagents for identifying anti-fungal agents, and uses related thereto
10/16/1997	WO1997038137A1 Hereditary hemochromatosis gene
10/16/1997	WO1997038129A1 Assays and reagents for identifying anti-fungal agents, and uses related thereto
10/16/1997	WO1997038123A1 Methods for producing soluble, biologically-active disulfide bond-containing eukaryotic proteins in bacterial cells
10/16/1997	WO1997038118A1 Defective viral vaccine particles obtained in vivo or ex vivo
10/16/1997	WO1997038110A2 Compositions and methods relating to drug discovery and detection and treatment of gastrointestinal diseases
10/16/1997	WO1997038109A1 Immunological rejection of transfected tumour cells
10/16/1997	WO1997038108A1 Expression of hgv antigens and their use
10/16/1997	WO1997038105A1 GENOMIC NUCLEIC ACIDS, cDNA AND mRNA WHICH CODE FOR POLYPEPTIDES WITH IL-16 ACTIVITY, PROCESSES FOR THE PRODUCTION THEREOF AND THEIR USE
10/16/1997	WO1997038104A1 Il-6 mutein
10/16/1997	WO1997038103A1 Il-6 mutein
10/16/1997	WO1997038102A1 Multivalent and multispecific antigen-binding protein
10/16/1997	WO1997038101A1 Scf analog compositions and methods
10/16/1997	WO1997038100A1 Human cachexia associated protein
10/16/1997	WO1997038099A1 Novel signal transducer
10/16/1997	WO1997038098A1 Human hyaluronan receptor
10/16/1997	WO1997038095A1 Complex superoxide dismutase product
10/16/1997	WO1997038089A1 Uses of oncofetal antigen specific cd4, cd8 cytotoxic and suppressor t cells and interleukin-10
10/16/1997	WO1997038085A2 Genes amplified in cancer cells
10/16/1997	WO1997038084A2 Polynucleotides derived from a pbmc cdna library encoding secreted proteins
10/16/1997	WO1997038082A2 Hypertonia gene
10/16/1997	WO1997038015A1 Artificial antibodies to corticosteroids prepared by molecular imprinting
10/16/1997	WO1997038014A1 Fibulin pharmaceutical compositions and related methods
10/16/1997	WO1997038013A1 Modulation of mammalian telomerase by peptide nucleic acids
10/16/1997	WO1997038012A1 Extracellular/epidermal growth factor hcaba58x
10/16/1997	WO1997038011A1 Non-dendritic backbone peptide carrier
10/16/1997	WO1997038009A1 Cyclic adhesion inhibitors
10/16/1997	WO1997038008A1 6-substituted amino-4-oxa-1-azabicyclo[3,2,0] heptan-7-one deriv atives as cysteine protease inhibitors
10/16/1997	WO1997038007A1 Peptidyl compounds having mmp and tnf- liberation inhibitory activity
10/16/1997	WO1997038004A1 Gene family associated with neurosensory defects
10/16/1997	WO1997038003A1 Human hematopoietic-specific protein
10/16/1997	WO1997038002A1 Extracellular/epidermal growth factor-like protein

1 ... 2678 2679 2680 2681 2682 2683 2684 2685 2686 2687 2688 2689 2690 2691 2692 2693 2694 2695 2696 2697 2698 ... 3163